New treatments for malignant melanoma

Doxorubicin-associated flare reactions.

Oncology nursing forum·1990

Extravasation of doxorubicin from vascular access devices.

Selective cancer therapeutics·1990

Ocular adverse reactions associated with adriamycin (doxorubicin).

American journal of ophthalmology·1989

Accidental acute exposure to doxorubicin.

Cancer nursing·1989

Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.

Medical and pediatric oncology·1988

Experimental skin necrosis produced by adriamycin.

Cancer treatment reports·1979

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

Cancer treatment reports·1987

IV melphalan in children.

Cancer treatment reports·1987

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Cancer treatment reports·1987

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Cancer treatment reports·1987

Doxorubicin distribution in human breast cancer.

Cancer treatment reports·1987

Phase I study of echinomycin.

Cancer treatment reports·1987

GATA1 knockdown enhances CD8+ T cell responses and protects against immune escape in cervical squamous cell carcinoma through FGL1 downregulation.

Journal of molecular histology·2026

Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

European journal of nuclear medicine and molecular imaging·2026

Efficacy and safety of adjuvant CDK4/6 inhibitors in hormone receptor-positive, HER2-negative early breast cancer: Updated evidence from a systematic review and meta-analysis.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Decision-to-outcome analysis of multidisciplinary tumor board-managed NSCLC patients.

Turk gogus kalp damar cerrahisi dergisi·2026

Electronic Structure Engineering at C7 Position of Thieno-Cytosine (thC): Toward Optimal Probe-Adduct Interactions with ABPG in DNA.

The journal of physical chemistry. B·2026

How Functional Variants Reconfigure the Rac2 Conformational Landscape.

The journal of physical chemistry. B·2026

Related Experiment Videos

New treatments for malignant melanoma

Related Concept Videos

Doxorubicin-associated flare reactions.

Extravasation of doxorubicin from vascular access devices.

Ocular adverse reactions associated with adriamycin (doxorubicin).

Accidental acute exposure to doxorubicin.

Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.

Experimental skin necrosis produced by adriamycin.

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

IV melphalan in children.

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Doxorubicin distribution in human breast cancer.

Phase I study of echinomycin.

GATA1 knockdown enhances CD8+ T cell responses and protects against immune escape in cervical squamous cell carcinoma through FGL1 downregulation.

Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

Efficacy and safety of adjuvant CDK4/6 inhibitors in hormone receptor-positive, HER2-negative early breast cancer: Updated evidence from a systematic review and meta-analysis.

Decision-to-outcome analysis of multidisciplinary tumor board-managed NSCLC patients.

Electronic Structure Engineering at C7 Position of Thieno-Cytosine (thC): Toward Optimal Probe-Adduct Interactions with ABPG in DNA.

How Functional Variants Reconfigure the Rac2 Conformational Landscape.

Related Experiment Videos

New treatments for malignant melanoma

Related Concept Videos

Related Articles